Proteomic Profiling of Stem Cell Differentiation
干细胞分化的蛋白质组学分析
基本信息
- 批准号:6889216
- 负责人:
- 金额:$ 15.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-05-01 至 2007-01-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Bone marrow mesenchymal stem cell (BMMSC) has potential to differentiate into different cell types. The long-term goal of this research is to control BMMSC differentiation in vitro and use BMMSC-derived smooth muscle cell (SMC) to construct tissue-engineered vascular grafts. The cyclic mechanical strain in the vessel wall and transforming growth factor 13(TGF-B) play important roles in SMC differentiation and vascular remodeling. The investigator has shown that both mechanical strain and TGF-I31 increase the expression of SMC markers in BMMSC. However, the underlying mechanisms and the proteomic changes of BMMSCs during differentiation are not well understood. Proteomic profiling provides a systematic and powerful approach to studying stem cell functions. The investigator hypothesizes: (1) BMMSC and its differentiation can be characterized by the expression of specific protein markers, and (2) mechanical strain and TGF-B] regulate BMMSC differentiation through distinct mechanisms and synergize the differentiation of BMMSCs into SMCs. Two specific aims are proposed in this exploratory/development study. In Aim 1, the investigator will determine the proteomic profile of BMMSC and identify potential markers of BMMSC. TGF-B] and other differentiation factors will be used to induce the proteome changes and differentiation of BMMSC. A comprehensive strategy using state-of-the-art technologies will be employed for proteome analysis. 2D gel electrophoresis and multidimensional liquid chromatography will be used for protein/peptide separation. Mass spectrometry will be used for protein identification and characterization. A reference map of BMMSC will be generated. The proteins only expressed in undifferentiated BMMSC will be identified. In Aim 2, the investigator will determine the proteome changes in BMMSC in response to mechanical strain and TGF-B. The proteins with changes in expression and post-translational modifications will be identified. Immobilized metal affinity capture will be employed for phosphopeptide enrichment. The global mechano-chemical signal transduction during BMMSC differentiation will be determined, and a map will be generated for the signaling pathways differentially regulated, shared, and synergized by mechanical strain and TGF-B]. Categorization and cluster analysis will be performed to correlate the proteins and signaling pathways. This study will advance our knowledge on BMMSC proteome and differentiation, and lead to more focused and in-depth biological studies in the future. The successful accomplishment of the goals will have high impact on stem cell engineering, and provide a rational basis for engineering BMMSC for vascular tissue repair.
描述(申请人提供):骨髓间充质干细胞(BMMSC)具有分化为不同细胞类型的潜能。本研究的长期目标是在体外控制BMMSC分化,并利用BMMSC来源的平滑肌细胞(SMC)构建组织工程血管移植物。血管壁的周期性机械应变和转化生长因子13(TGF-β)在SMC分化和血管重塑中起重要作用。研究者已经表明,机械应变和TGF-β 1均增加BMMSC中SMC标志物的表达。然而,BMMSCs在分化过程中的潜在机制和蛋白质组学变化还不清楚。蛋白质组学分析为研究干细胞功能提供了一种系统而有力的方法。研究者假设:(1)BMMSC及其分化可以通过表达特异性蛋白标志物来表征;(2)机械应变和TGF-β 1通过不同的机制调节BMMSC的分化,并协同BMMSC向SMC的分化。本探索性/开发研究提出了两个具体目标。在目标1中,研究者将确定BMMSC的蛋白质组学谱并鉴定BMMSC的潜在标志物。TGF-β]和其他分化因子将用于诱导BMMSC的蛋白质组变化和分化。蛋白质组分析将采用采用最先进技术的综合策略。2D凝胶电泳和多维液相色谱将用于蛋白质/肽分离。质谱法将用于蛋白质鉴定和表征。将生成BMMSC的参考地图。将鉴定仅在未分化的BMMSC中表达的蛋白质。在目标2中,研究者将确定BMMSC中响应于机械应变和TGF-β的蛋白质组变化。将鉴定具有表达变化和翻译后修饰的蛋白质。固定化金属亲和捕获将用于磷酸肽富集。将确定BMMSC分化期间的整体机械化学信号转导,并将生成由机械应变和TGF-β差异调节、共享和协同的信号传导途径的图谱。将进行分类和聚类分析,以将蛋白质和信号通路相关联。本研究将进一步加深我们对BMMSC蛋白质组和分化的认识,并在未来进行更集中和深入的生物学研究。这一目标的成功实现将对干细胞工程产生重大影响,并为血管组织修复工程提供理论依据。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Song Li其他文献
Song Li的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Song Li', 18)}}的其他基金
Nanoparticles-mediated combination therapy for breast cancer
纳米颗粒介导的乳腺癌联合疗法
- 批准号:
10617544 - 财政年份:2023
- 资助金额:
$ 15.51万 - 项目类别:
Multimodal wireless electrical stimulation for tissue regeneration
用于组织再生的多模式无线电刺激
- 批准号:
10615764 - 财政年份:2022
- 资助金额:
$ 15.51万 - 项目类别:
Study of Interleukin 33 as a new immunotherapy of lung cancer
白细胞介素33作为肺癌新型免疫疗法的研究
- 批准号:
10703786 - 财政年份:2022
- 资助金额:
$ 15.51万 - 项目类别:
Regulation of cell reprogramming by matrix stiffness
通过基质硬度调节细胞重编程
- 批准号:
10281141 - 财政年份:2021
- 资助金额:
$ 15.51万 - 项目类别:
Regulation of cell reprogramming by matrix stiffness
通过基质硬度调节细胞重编程
- 批准号:
10491279 - 财政年份:2021
- 资助金额:
$ 15.51万 - 项目类别:
Regulation of cell reprogramming by matrix stiffness
通过基质硬度调节细胞重编程
- 批准号:
10687264 - 财政年份:2021
- 资助金额:
$ 15.51万 - 项目类别:
Study of Interleukin 33 as a new immunotherapy of lung cancer
白细胞介素33作为肺癌新型免疫疗法的研究
- 批准号:
10442707 - 财政年份:2019
- 资助金额:
$ 15.51万 - 项目类别:
Study of Interleukin 33 as a new immunotherapy of lung cancer
白细胞介素33作为肺癌新型免疫疗法的研究
- 批准号:
10202507 - 财政年份:2019
- 资助金额:
$ 15.51万 - 项目类别:
相似海外基金
ROLE OF CELL ADHESION IN BIOLOGICAL SIGNAL TRANSDUCTION
细胞粘附在生物信号转导中的作用
- 批准号:
6238317 - 财政年份:1997
- 资助金额:
$ 15.51万 - 项目类别:
ROLE OF CELL ADHESION IN BIOLOGICAL SIGNAL TRANSDUCTION
细胞粘附在生物信号转导中的作用
- 批准号:
5210031 - 财政年份:
- 资助金额:
$ 15.51万 - 项目类别: